Ieq Capital LLC Acquires New Holdings in Nutrien Ltd. $NTR

Ieq Capital LLC bought a new position in shares of Nutrien Ltd. (NYSE:NTR) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 10,173 shares of the company’s stock, valued at approximately $640,000.

A number of other institutional investors have also recently added to or reduced their stakes in NTR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Nutrien by 65.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,224 shares of the company’s stock worth $1,253,000 after purchasing an additional 9,950 shares during the last quarter. NewEdge Advisors LLC increased its holdings in Nutrien by 6.2% in the first quarter. NewEdge Advisors LLC now owns 6,907 shares of the company’s stock valued at $343,000 after purchasing an additional 404 shares during the period. Focus Partners Wealth bought a new position in Nutrien during the 1st quarter worth $516,000. Acadian Asset Management LLC acquired a new position in Nutrien during the 1st quarter worth about $54,000. Finally, Prudential Financial Inc. acquired a new position in Nutrien during the 2nd quarter worth about $203,000. 63.10% of the stock is owned by institutional investors.

Nutrien Stock Performance

NTR stock opened at $73.64 on Friday. The firm has a market cap of $35.23 billion, a PE ratio of 14.91, a price-to-earnings-growth ratio of 0.78 and a beta of 0.61. The company has a current ratio of 1.39, a quick ratio of 0.86 and a debt-to-equity ratio of 0.36. The stock has a 50-day moving average price of $67.33 and a 200-day moving average price of $70.56. Nutrien Ltd. has a 1-year low of $53.03 and a 1-year high of $85.36.

Nutrien (NYSE:NTR) last announced its earnings results on Wednesday, August 5th. The company reported $2.61 EPS for the quarter, missing the consensus estimate of $2.70 by ($0.09). Nutrien had a net margin of 8.44% and a return on equity of 8.88%. The business had revenue of $10.81 billion for the quarter, compared to the consensus estimate of $10.44 billion. During the same quarter in the previous year, the company earned $2.65 EPS. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. As a group, equities research analysts expect that Nutrien Ltd. will post 4.71 earnings per share for the current year.

Nutrien Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 16th. Stockholders of record on Tuesday, September 29th will be given a dividend of $0.55 per share. The ex-dividend date of this dividend is Tuesday, September 29th. This represents a $2.20 annualized dividend and a dividend yield of 3.0%. Nutrien’s dividend payout ratio (DPR) is 44.53%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on NTR. BNP Paribas Exane upgraded Nutrien from a “neutral” rating to an “outperform” rating and set a $80.00 price target on the stock in a research report on Tuesday, July 28th. UBS Group cut their price objective on Nutrien from $67.00 to $65.00 and set a “sell” rating on the stock in a research note on Monday, May 11th. Scotiabank upgraded Nutrien from a “sector perform” rating to a “sector outperform” rating and set a $80.00 target price on the stock in a report on Tuesday, June 30th. Morgan Stanley decreased their target price on shares of Nutrien from $93.00 to $81.00 and set an “overweight” rating for the company in a research report on Tuesday, July 7th. Finally, Berenberg Bank set a $65.00 price target on shares of Nutrien and gave the stock a “hold” rating in a report on Wednesday, June 10th. Seventeen investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $81.58.

Key Nutrien News

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $4.38 from $3.66, a substantial improvement that suggests stronger expected profitability. The firm also lifted estimates for Q2 2027, Q4 2027, FY2026, FY2028, Q1 2027, Q3 2027, Q4 2026 and Q2 2028. Collectively, the revisions point to improving longer-term earnings expectations.
• Positive Sentiment: An investor article emphasizes the appeal of not missing another year of Nutrien’s dividend income, which may reinforce the stock’s attraction to income-oriented investors. You’ve Already Missed a Year of Dividends: Here’s Why I Wouldn’t Miss Another
• Neutral Sentiment: Nutrien’s estimated current-year EPS remains below the broader consensus at $4.71 versus $4.95, while FY2027 and FY2028 estimates are $4.38 and $4.23, respectively. This indicates improving expectations but not an across-the-board bullish outlook.
• Negative Sentiment: Zacks Research reduced its Q3 2026 EPS estimate to $0.78 from $0.92 and its Q1 2028 estimate to $0.63 from $0.76. These cuts signal potential near-term earnings pressure and could limit the stock’s upside.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.